首页 | 本学科首页   官方微博 | 高级检索  
     

Caveolin-1在乳腺癌间质中的表达及与预后的关系
引用本文:李建华,吕伟鹏,朱瑞萍,曹铭谦. Caveolin-1在乳腺癌间质中的表达及与预后的关系[J]. 大连医科大学学报, 2017, 39(2): 132-136. DOI: 10.11724/jdmu.2017.02.06
作者姓名:李建华  吕伟鹏  朱瑞萍  曹铭谦
作者单位:1. 大连大学附属中山医院 病理科,辽宁 大连,116001;2. 大连大学附属中山医院 乳腺科,辽宁 大连,116001
摘    要:目的 检测Cav-1在乳腺癌间质中的表达,探讨其与临床病理学指标,乳腺癌分子亚型及与三阴型乳腺癌预后的关系.方法 选取258例有完整随访资料的乳腺癌切除标本,用免疫组织化学方法 检测间质中CAF细胞的Cav-1表达,与肿瘤临床T分期、病理分级、淋巴结转移情况及肿瘤细胞分子标记物(ER、PR、HER-2、P53、PCNA)的表达情况进行相关性分析,同时分析在Luminal A型、Luminal B型、HER-2型和三阴型中Cav-1的差异性表达,并在三阴型乳腺癌中根据Cav-1的表达进行生存分析.结果 258例乳腺病例中,78例间质Cav-1的阴性/微弱阳性表达,94例中等阳性表达,86例强阳性表达.肿瘤分期越高,Cav-1的表达的阳性率越低,T1、T2及T3~T4各组之间差异有显著性意义(P<0.05).有淋巴结转移的肿瘤比无淋巴结转移的肿瘤Cav-1表达水平低,二者具有显著性差异(P<0.05).与患者年龄、肿瘤大小、ER、PR和HER-2的状态无关.三阴型乳腺癌与Luminal A型、B型、HER-2型相比, Cav-1的表达明显降低(P<0.05),而A型、B型、HER-2型之间无明显差异.三阴型乳腺癌间质中Cav-1(-)、Cav-1(+)、Cav-1(++)三组生存率差异有显著性(P<0.05),Cav-1的表达缺失是三阴型乳腺癌预后差的独立预后指标(HR=1.583 95%CI=1.031-2.431,P<0.05).结论 Cav-1表达水平随着临床分期的增高而降低;间质中Cav-1是三阴型乳腺癌的独立预后指标,Cav-1的低表达与预后差密切相关.

关 键 词:Caveolin-1  乳腺癌  肿瘤间质  预后
收稿时间:2017-03-01

Expression of caveolin-1 in cancer-associated fibroblasts as a prognostic indicator in breast cancer
LI Jianhu,LYU Weipeng,ZHU Ruiping and CAO Mingqian. Expression of caveolin-1 in cancer-associated fibroblasts as a prognostic indicator in breast cancer[J]. Journal of Dalian Medical University, 2017, 39(2): 132-136. DOI: 10.11724/jdmu.2017.02.06
Authors:LI Jianhu  LYU Weipeng  ZHU Ruiping  CAO Mingqian
Affiliation:Department of Pathology, Zhongshan Affiliated Hospital of Dalian University, Dalian 116001,China,Department of Pathology, Zhongshan Affiliated Hospital of Dalian University, Dalian 116001,China,Department of Pathology, Zhongshan Affiliated Hospital of Dalian University, Dalian 116001,China and Department of Breast Surgery, Zhongshan Affiliated Hospital of Dalian University, Dalian 116001,China
Abstract:Objective To investigate the stromal caveolin-1(Cav-1) expression and its association with clinicalpathologic parameters, molecular subtypes of breast cancer and its prognostic significance.Methods Cav-1 expression was detected in the stroma of 258 breast cancer patients with at least 10 years of follow-up in IHC.Three groups were divided according to the staining strength (weak-, moderate+ and strong ++).Differential expression was analyzed in the light of clinical stage, pathology grade, lymphatic metastasis and the expression of molecular markers (ER,PR,HER-2,P53 and PCNA).Further analysis was performed in Luminal A, Luminal B, HER-2 and triple negative subtypes of breast cancer.Results Overexpression of stromal Cav-1 in breast cancer was associated with early stage(P=0.014) and no lymph node metastasis(P=0.011).The expression had no relationship with histological grade,ER status,PR status,HER-2 status, p53 status and PCNA status.Stromal Cav-1 expression in TN breast cancer was significantly lower than that in Luminal A, Luminal B, HER-2 molecular subtypes (P=0.014,0.035 and 0.047 respictively).Furthermore, stromal expression of Cav-1 was significantly correlated with the progression-free survival(P=0.033) and overall survival rate(P=0.031).Conclusion The absence or reduction of Cav-1 expression in stromal CAFs of invasive breast cancer would predict the poor prognostic outcome.Stromal Cav-1 expression would become a prognostic indicator.
Keywords:Caveolin-1  breast cancer  cancer-associated fibroblast  prognostic outcome
本文献已被 万方数据 等数据库收录!
点击此处可从《大连医科大学学报》浏览原始摘要信息
点击此处可从《大连医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号